The Canadian Food Inspection Agency (CFIA) has provided updates on its sampling and testing activities of retail milk for the presence of highly pathogenic avian influenza (HPAI) viral fragments. Additionally, Health Canada and CFIA recently completed a study on pasteurization’s efficacy against HPAI in milk.
Following a lead poisoning outbreak linked to adulterated cinnamon fruit puree pouches that affected hundreds of children, the U.S. Food and Drug Administration (FDA) issued a warning letter to Dollar Tree, Inc. due to its failure to remove the recalled products from stores.
The National Association of Wine Retailers (NAWR) has published a paper that provides a comprehensive overview of U.S. regulation of alcohol sales, the challenges within the current system, and possibly beneficial regulatory changes.
A recent article identifies the challenges associated with allergenicity assessments of novel proteins and proposes a potential framework to prioritize proteins for allergenicity assessment.
The EU Heads of Food Safety Agencies (HoA) recently published a list of 117 substances that should be prohibited or restricted in food supplements to protect public health.
In collaboration with supply chain partners, ExxonMobil has successfully helped develop a recyclable MDO-PE//PE laminate, suitable for a variety of foods and liquids.
The U.S. Food and Drug Administration (FDA) has issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Final Rule, fulfilling Subpart 204 of the Food Safety Modernization Act (FSMA 204).
The European Commission is taking strides to improve honey authenticity, including setting new origin labeling requirements, and the development of harmonized traceability requirements and improved methods of composition analysis and origin tracing. The Commission is assembling a group of experts called the “Honey Platform” to advise this work and is accepting applications.
The infant formula shortage of 2022 was precipitated by FDA’s delayed response to whistleblower complaints about contaminated product—a delay caused by the agency not having the necessary policies and procedures in place to address the issue at the time—according to a new report published by the U.S. DHHS’ Office of the Inspector General.
